Evidence map›Paper›PMID 24198371›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

Neuroprotective role of a brain-enriched tyrosine phosphatase, STEP, in focal cerebral ischemia.

Ishani Deb, Namratta Manhas, Ranjana Poddar, Sathyanarayanan Rajagopal, Andrea M Allan, Paul J Lombroso, Gary A Rosenberg, Eduardo Candelario-Jalil, Surojit Paul

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Functions of p38 MAP Kinases in the Central Nervous System.Frontiers in molecular neuroscience · 2020
    Review
  9. Article
  10. A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ishani DebDepartments of Neurology and Neurosciences, University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque, New Mexico 87131, Yale University School of Medicine, Child Study Center, New Haven, Connecticut 06519, and Department of Neuroscience, University of Florida, Gainesville, Florida 32610.
Namratta Manhas
Ranjana Poddar
Sathyanarayanan Rajagopal
Andrea M Allan
Paul J Lombroso
Gary A Rosenberg
Eduardo Candelario-Jalil
Surojit Paul
University of New Mexico · USUniversity of Florida · USYale University · US

Funding

ROLE OF STEP, A STRIATAL ENRICHED TYROSINE PHOSPHATASE, IN NEURONAL CELL DEATHP20RR015636 · NCRR · UNIVERSITY OF NEW MEXICO · PI LIU, KE JIAN · 2001 to 2010
$21.2M
Role of Brain Specific Tyrosne Phosphatase STEP in Neuroprotection and DeathR01NS059962 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PAUL, SUROJIT · 2008 to 2023
$5.9M
MOLECULAR AND CELLULAR ANALYSIS OF BRAIN ENRICHED PTPSR01MH052711 · NIMH · YALE UNIVERSITY · PI LOMBROSO, PAUL J · 1999 to 2014
$5.0M
White matter hypoxia in a novel model of MMP-mediated inflammation in SHR/SPR01NS045847 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ROSENBERG, GARY ALLEN · 2003 to 2017
$3.7M
Cyclooxygenase-2 Regulation of Blood-Brain Barrier Opening in Ischemic StrokeR01NS065849 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CANDELARIO-JALIL, EDUARDO JESUS · 2011 to 2015
$1.5M
Molecular basis of homocysteine-glutamate receptor mediated neuronal cell deathR21NS065343 · NINDS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PODDAR, RANJANA · 2011 to 2012
$415k
MOLECULAR AND CELLULAR ANALYSES OF BRAIN ENRICHED PTPSR29MH052711 · NIMH · YALE UNIVERSITY · PI LOMBROSO, PAUL J · 1994 to 1998
–
NCRR NIH HHS 3P20RR015636-09 S1NCRR NIH HHS P20 RR015636NIMH NIH HHS MH052711NIMH NIH HHS R01 MH052711NINDS NIH HHS NS059962NINDS NIH HHS NS065343NINDS NIH HHS R01 NS045847NINDS NIH HHS R01 NS059962NINDS NIH HHS R01 NS065849NINDS NIH HHS R21 NS065343
6 · The paper itself

Abstract

The striatal-enriched phosphatase (STEP) is a component of the NMDA-receptor-mediated excitotoxic signaling pathway, which plays a key role in ischemic brain injury. Using neuronal cultures and a rat model of ischemic stroke, we show that STEP plays an initial role in neuroprotection, during the insult, by disrupting the p38 MAPK pathway. Degradation of active STEP during reperfusion precedes ischemic brain damage and is associated with secondary activation of p38 MAPK. Application of a cell-permeable STEP-derived peptide that is resistant to degradation and binds to p38 MAPK protects cultured neurons from hypoxia-reoxygenation injury and reduces ischemic brain damage when injected up to 6 h after the insult. Conversely, genetic deletion of STEP in mice leads to sustained p38 MAPK activation and exacerbates brain injury and neurological deficits after ischemia. Administration of the STEP-derived peptide at the onset of reperfusion not only prevents the sustained p38 MAPK activation but also reduces ischemic brain damage in STEP KO mice. The findings indicate a neuroprotective role of STEP and suggest a potential role of the STEP-derived peptide in stroke therapy.

Indexed as

AnimalsBrain IschemiaCells, CulturedCorpus StriatumDown-RegulationMaleMiceNeuronsp38 Mitogen-Activated Protein KinasesProtein Tyrosine Phosphatases, Non-ReceptorRatsRats, Sprague-DawleyRats, WistarSignal TransductionStrokep38 Mitogen-Activated Protein KinasesProtein Tyrosine Phosphatases, Non-ReceptorPtpn5 protein, rat

Identifiers

PMID24198371
PMCPMC3818554
OpenAlexW2000597812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.